Thymic carcinoma with overexpression of mutated KIT and the response to imatinib

被引：149

作者：

Strobel, P ^{[1
]}

Hartmann, M

Jakob, A

Mikesch, K

Brink, I

Dirnhofer, S

Marx, A

机构：

[1] Univ Wurzburg, Inst Pathol, D-97080 Wurzburg, Germany

[2] Offenburg Hosp, D-77654 Offenburg, Germany

[3] Univ Freiburg, D-79106 Freiburg, Germany

[4] Univ Basel, Inst Pathol, CH-4003 Basel, Switzerland

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2004年 / 350卷 / 25期

关键词：

D O I：

10.1056/NEJM200406173502523

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

页码：2625 / 2626

页数：2

共 5 条

[1]

Allander SV, 2001, CANCER RES, V61, P8624

[2]

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors [J].

Demetri, GD ;

von Mehren, M ;

Blanke, CD ;

Van den Abbeele, AD ;

Eisenberg, B ;

Roberts, PJ ;

Heinrich, MC ;

Tuveson, DA ;

Singer, S ;

Janicek, M ;

Fletcher, JA ;

Silverman, SG ;

Silberman, SL ;

Capdeville, R ;

Kiese, B ;

Peng, B ;

Dimitrijevic, S ;

Druker, BJ ;

Corless, C ;

Fletcher, CDM ;

Joensuu, H .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) :472-480

[3]

PDGFRA activating mutations in gastrointestinal stromal tumors [J].

Heinrich, MC ;

Corless, CL ;

Duensing, A ;

McGreevey, L ;

Chen, CJ ;

Joseph, N ;

Singer, S ;

Griffith, DJ ;

Haley, A ;

Town, A ;

Demetri, GD ;

Fletcher, CDM ;

Fletcher, JA .

SCIENCE, 2003, 299 (5607) :708-710

[4]

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor [J].

Heinrich, MC ;

Corless, CL ;

Demetri, GD ;

Blanke, CD ;

von Mehren, M ;

Joensuu, H ;

McGreevey, LS ;

Chen, CJ ;

Van den Abbeele, AD ;

Druker, BJ ;

Kiese, B ;

Eisenberg, B ;

Roberts, PJ ;

Singer, S ;

Fletcher, CDM ;

Silberman, S ;

Dimitrijevic, S ;

Fletcher, JA .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (23) :4342-4349

[5]

Rosai J, 1999, HISTOLOGICAL TYPING

← 1 →